Stay updated with breaking news from Warren Huff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Reata Pharmaceuticals, Inc. , a global, biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases, announced that at a special meeting...
The rare-disease drug maker will add to Biogen's portfolio.
SKYCLARYS® recently approved in US as the only treatment indicated for patients with Friedreich’s ataxia Proposed acquisition represents meaningful step…
Biogen to Acquire Reata Pharmaceuticals SKYCLARYS® recently approved in US as the only treatment indicated for patients with Friedreich's...
Reata Pharmaceuticals, Inc. , a global biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases, announced the appointment of Rajiv... | June 13, 2023